A system for quickly identifying infectious diseases at the point of care.
Official title: A modular platform for infectious disease surveillance at point-of-need.
Funded at Redbud Labs, INC. · NIH-10697143 · Data updated 2026-11-12
This study is working on a quick and easy test that can check for several infectious diseases, like Ebola and Dengue, using just a small blood sample, so that patients can get results in under 30 minutes, helping doctors make faster decisions during outbreaks and keep track of diseases even when there aren’t any outbreaks happening.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Redbud Labs, INC. NIH-funded |
| Lab location | 1 site (Durham, UNITED STATES) |
| Project start | August 7, 2020 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $983,642 |
| NIH project number | 5R44AI150263-04 |
| Project ID | NIH-10697143 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals presenting symptoms of infectious diseases that may require rapid diagnosis, especially during outbreaks.
✕Less likely to help
Patients with non-infectious diseases or those not exhibiting symptoms of the targeted infectious diseases may not benefit from this research.
What this research studies
This research aims to create a rapid testing platform that can identify various infectious diseases, particularly filoviruses like Ebola and Dengue, directly at the point of need. By using a small blood sample, the system will test for multiple viral strains simultaneously, providing results in under 30 minutes. This technology is designed to improve patient triage and treatment during outbreaks and enhance disease surveillance even when outbreaks are not occurring. The approach combines advanced microfluidic technology with expertise in diagnostics to ensure accurate and timely identification of infections.
Why it matters
Potential benefit: If successful, this research could significantly reduce the time it takes to diagnose serious infectious diseases, leading to faster treatment and better outbreak management.
How similar studies have gone: Other research has shown promise in developing rapid diagnostic tests for infectious diseases, indicating that this approach has potential for success.
Where this research is happening
-
Redbud Labs, INC.
Durham, United States Active
Researchers
- Principal investigator: Fisher, Jay Kenneth — Redbud Labs, INC.
- Study coordinator: Fisher, Jay Kenneth
Related research
Other NIH-funded projects on the same topics.
-
Latin American Center for Emerging Infectious Disease Surveillance and Readiness
A regional collaboration in Peru and neighboring countries aims to strengthen early warning and monitoring for viruses that could jump from animals to people, helping communities prepare for outbreaks.
-
Center in Latin America to monitor emerging infectious diseases
A U01 grant supporting a collaboration between Peruvian and U.S. researchers to improve early detection and surveillance of regionally relevant viruses that could affect people, animals, and crops in Peru and neighboring areas.
-
Acanthamoeba as a modern model parasite to study infectious disease biology and mitochondria
A five-year project will define the mitochondrial proteins and pathways of Acanthamoeba castellanii to advance infectious disease biology and parasite metabolism.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
-
Multi-omic endotypes of vaccine response, respiratory infections, and asthma in children
A parent-friendly look at how early-life immune development shapes how kids respond to vaccines and stay free from lung infections and asthma, using advanced biological profiling.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.